Topical treatment of field cancerization.
Ulrich
Claas
C
Department of Dermatology, Transplant-Aftercare Unit, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
D000634:Aminoquinolines / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D017209:Apoptosis; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control; D004008:Diclofenac / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D000077271:Imiquimod; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D055623:Keratosis, Actinic / Q000209:etiology / Q000628:therapy; D016377:Organ Transplantation / Q000009:adverse effects; D010778:Photochemotherapy / Q000379:methods; D012008:Recurrence; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000209:etiology*; D014018:Tissue Distribution
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D004008:Diclofenac; D000077271:Imiquimod; D005472:Fluorouracil